3,469 results on '"Lymphohistiocytosis, Hemophagocytic"'
Search Results
2. CytOSorb TreatMent Of Critically Ill PatientS Registry (COSMOS)
3. Retrospective Study of Immunotherapy Related Toxicities and Factors Impacting Outcomes in Children and Adults With Cancer
4. Baby Detect : Genomic Newborn Screening
5. Evaluate Efficacy, Safety and Tolerability, PK and PD of Emapalumab in Children and Adults With MAS in Still's or SLE (EMERALD)
6. Safety Study of Gene Modified Donor T Cell Infusion After Stem Cell Transplant for Non-Malignant Diseases
7. Use Of A Response-Adapted Ruxolitinib-Containing Regimen For The Treatment Of Hemophagocytic Lymphohistiocytosis
8. Study to Assess the Efficacy and Safety of Emapalumab in Primary Haemophagocytic Lymphohistiocytosis
9. A Post-authorization Study to Describe the Safety and Efficacy of Emapalumab for the Treatment of pHLH in Treatment Experienced Chinese Patients
10. JAK Inhibitor in Acquired Hemophagocytic synDrome in the Intensive Care Unit (JAKAHDI)
11. Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies
12. Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford (CoRDS)
13. Haploidentical Hematopoietic Cell Transplantation Using TCR Alpha/Beta and CD19 Depletion (HAPLOTAB)
14. Alemtuzumab or Tocilizumab in Combination With Etoposide and Dexamethasone for the Treatment of Adult Patients With Hemophagocytic Lymphohistiocytosis
15. INTO-HLH: A Disease Registry for Patients With Hemophagocytic Lymphohistiocytosis (HLH)
16. Ruxolitinib as First Line Treatment in Primary Haemophagocytic Lymphohistiocytosis (R-HLH) (R-HLH)
17. Ruxolitinib With De-Intensified HLH-94 for the Treatment of Hemophagocytic Lymphohistiocytosis (HLH)
18. Prospective Cohort for Adult Hemophagocytosis
19. Clinical Study of EBV-TCR-T Cells for EBV-associated Hemophagocytic Lymphohistiocytosis or EBV Infection
20. Segmental Resection Combined With DEP Regimen for EBV-HLH Patients With Intestinal Involvement
21. Early Detection of Epstein-Barr Virus Related Disease.
22. Evaluation of the Safety and Efficacy of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis
23. A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Emapalumab in Adult Patients With HLH
24. Evaluation of IFNγ and Inflammatory Mediators in Patients With Hemophagocytic Lymphohistiocytosis
25. Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation
26. GTP Regimen in the Treatment of Refractory/Recurrent HLH
27. A Randomized Controlled Study of High-dose Cyclophosphamide Induction Therapy in Adult Patients With HLH
28. Efficacy and Safety of Carrimycin Tablets in HLH Patients With Carbapenem-resistant Infections
29. Immune Disorder HSCT Protocol
30. Administration of Donor T Cells With the Caspase-9 Suicide Gene (DOTTI)
31. Clinical Study of Donor EBV-CTL Infusion in Patients With CAEBV and EBV-HLH After Allo-HSCT
32. Describing Treatment Outcomes and Responses in Lymphoma-associated Hemophagocytic Lymphohistiocytosis
33. Prospective Validation of the OHI Index (HLH)
34. HLH Patients - a Retrospective Study
35. Prospective Study of Immune Function and PD-1 Antibody Therapy Efficacy Predictors on CAEBV and EBV-HLH Patients
36. L-DEP Regimen Combined With PD-1 Antibody as Induction Therapy for Epstein-Barr Virus-positive LA-HLH
37. Study to Investigate Safety, Efficacy of an Anti-IFNγ mAb in Children With Primary Haemophagocytic Lymphohistiocytosis
38. Assessing the Presence of CT-DNA in Lymphoma Associated HLH
39. Response Prediction in EBV-HLH Using Metabonomics Analysis
40. Diagnostic Biomarkers for Adult Hemophagocytic Lymphohistiocytosis in Critically Ill Patients (HEMICU)
41. Correlation between Aspartate Aminotransferase/Alanine Aminotransferase and Prognosis of Hemophagocytic Lymphohistiocytosis in Children
42. Reduced Intensity Conditioning for Hemophagocytic Syndromes or Selected Primary Immune Deficiencies (BMT CTN 1204) (RICHI)
43. Investigation of Ferritin in Critically Ill Patients With Hemophagocytic Lymphohistiocytosis (FERRITS)
44. Sensitivity and Specificity of Cytokines in the Diagnosis of Lymphoma-associated HLH
45. Cytokine Guided Risk Stratification and Treatment in Pediatric Hemophagocytic Lymphohistiocytosis
46. Efficacy and Safety of Venetoclax Combined With Dexamethasone and Etoposide in HLH
47. A Study for Long-term Follow-up of Hemophagocytic Lymphohistiocytosis (HLH) Participants Who Received Treatment With Emapalumab (NI-0501), an Anti-interferon Gamma Monoclonal Antibody
48. Rituximab Monotherapy for EBV-HLH and CAEBV
49. A Study to Investigate the Safety and Efficacy of Emapalumab, an Anti-IFN-gamma mAb in Patients With Systemic Juvenile Idiopathic Arthritis (sJIA) or Adult-onset Still's Disease (AOSD) Developing Macrophage Activation Syndrome/Secondary HLH (MAS/sHLH)
50. Study on Pharmacokinetics of Meperizumab Injection and NUCALA® in Healthy Male Volunteers
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.